Clinical Trial

Esketamine Versus Sufentanil for Sedation in Patients Undergoing ERCP

Study acronym: ES-ERCP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study compares two anesthesia medications, esketamine and sufentanil, used together with propofol during ERCP procedures. The goal is to find out which combination provides better safety and comfort for people undergoing ERCP. Participants will be randomly assigned to receive either esketamine or sufentanil during sedation. Researchers will monitor blood oxygen levels, blood pressure, and recovery time during and after the procedure to evaluate safety and effectiveness.
Trial Details
NCT Number NCT07702240
Lead Sponsor Ren Da
Conditions Biliary Tract Diseases, Procedural Sedation and Analgesia
Enrollment 530 participants
Start Date 2026-07-10
Primary Completion 2028-03-10 (estimated)
Study Completion 2028-03-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-14